CHAOJU EYE CARE Subsidiary Invests $16 Million in Structured Deposit
Stock News
Jul 23
An indirect wholly-owned subsidiary of CHAOJU EYE CARE (02219) has made a significant investment in a financial product.
On July 23, 2026, Chaoju Eye Care Medical (Hong Kong) Company Limited, known as Chaoju Hong Kong, subscribed for a structured deposit product with a total principal amount of US$16 million. The product is provided by JPMorgan Chase Bank.
The funding for this subscription was sourced from the group's surplus cash reserves and was not derived from the proceeds of its global offering.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.